(Q37755109)

22 August 2017

Adipose tissue and the metabolic syndrome: focusing on adiponectin and several novel adipokines (English)

1 reference

22 August 2017

1 reference

Annette Wk Tso

1

1 reference

22 August 2017

Aimin Xu

series ordinal

2

1 reference

22 August 2017

Wing Sun Chow

series ordinal

3

1 reference

22 August 2017

Karen Sl Lam

series ordinal

4

1 reference

22 August 2017

1 June 2008

1 reference

22 August 2017

Biomarkers in Medicine

1 reference

22 August 2017

2

1 reference

22 August 2017

3

1 reference

22 August 2017

239-252

1 reference

Banting lecture 1988. Role of insulin resistance in human disease

22 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Visceral obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Post-translational modifications of adiponectin: mechanisms and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Association of hypoadiponectinemia with impaired vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Hypoadiponectinemia is an independent risk factor for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin as a biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Association of the human adiponectin gene and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Polymorphisms of the gene encoding adiponectin and glycaemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin: protection of the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Changes of adiponectin oligomer composition by moderate weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Role of the fatty acid binding protein mal1 in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Retinol-binding protein 4 in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Identification of a new acute phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17520363.2.3.239

21 January 2018

Identifiers

DOI

10.2217/17520363.2.3.239

1 reference

22 August 2017

1 reference